Galadlas, Avilino .

HRN: 04-17-38  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/23/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
03/23/2025
03/29/2025
IV
1.5g
Q8
Pneumoperitonium
Waiting Final Action 
03/23/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/23/2025
03/29/2025
IV
500 Mg
Q8h
Intraabdominal Infection
Waiting Final Action 
03/29/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/29/2025
04/05/2025
IV
4.5gm
Q6
Sepsis
Waiting Final Action 
03/31/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/31/2025
04/06/2025
IV
500mg
Q8h
Bleeding Peptic Ulcer Disease
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: